| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/22/2006 | US7094599 Therapeutic cells which express a membrane-bound, chimeric, proteinaceous receptor comprising an extracellular CD4 fragment to bind an HIV-infected cell without contracting the infection and an intracellular portion to destroy it |
| 08/22/2006 | US7094598 gene expression vectors comprising enhancers having sequence identity to dna sequences, that elicit immune responses against viral disease |
| 08/22/2006 | US7094597 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 08/22/2006 | US7094591 propteins and/or polypeptides coded by polynucleotides, used for medical diagnosis, drug screening or prophylaxis of rheumatic disease and respiratory system disorders |
| 08/22/2006 | US7094590 Aggrecanase |
| 08/22/2006 | US7094589 53010, A novel human carboxylesterase family member and uses thereof |
| 08/22/2006 | US7094588 Variant EGIII-like cellulase compositions |
| 08/22/2006 | US7094586 Transglutaminase from oomycetes |
| 08/22/2006 | US7094585 genetic engineered nucleotide sequences that code polypeptides used as biosensors for measurement of glucose using enzyme electrodes |
| 08/22/2006 | US7094584 strains of corynebacterium having lysine export carrier, dihydrodipicolinate synthase, aspartokinase and dihydrodipicolinate reductase gene overexpression; genetic vectors and host cells comprising nucleotide sequences linked to these genes; biosynthesis |
| 08/22/2006 | US7094583 mixtures of dextrins and sugars used for enhanced delivery of eucaryotic expression vectors, to cells in vivo; gene therapy |
| 08/22/2006 | US7094579 Providing a culture of bacterial cells, adding rhanmose to the culture to induce rhamnose promoter whereby the antibody heavy chain and light chain and their linked signal sequences are expressed, secreted to the periplasm |
| 08/22/2006 | US7094578 α1,2 fucosyltransferase |
| 08/22/2006 | US7094577 Insulin and albumin fusion protein |
| 08/22/2006 | US7094576 Detecting helminth infection using synthetic larval proteins; immunoassay; parasiticides |
| 08/22/2006 | US7094575 For prophylaxis and therapy of phospholipase A2 (PLA2) related inflammatory conditions |
| 08/22/2006 | US7094574 Recombinant cell clones having increased stability and methods of making and using the same |
| 08/22/2006 | US7094573 ribosome binding site sequences, genetic vectors containing such sequences, and host cells transformed with these vectors, used for biosynthesis proteins and fragments in prokaryotic cells |
| 08/22/2006 | US7094572 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74 |
| 08/22/2006 | US7094571 Combinatorial protein library screening by periplasmic expression |
| 08/22/2006 | US7094569 Polypeptide for use in the treatment and prevention of alopecia |
| 08/22/2006 | US7094568 Generation of preferential proteins; provide nucleotide sequences, amplify, incubate nucleotide sequences with nuclease, clone sequences into expression vector, express coded proteins, recover proteins |
| 08/22/2006 | US7094567 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/22/2006 | US7094566 IL-17 receptor like molecules and uses thereof |
| 08/22/2006 | US7094565 polynucleotides that code polypeptides having oxidoreductase or alcohol dehydrogenase activity, used for drug screening, diagnosis and prophylaxis of brain, gastrointerstinal or urogenital disorders |
| 08/22/2006 | US7094564 polynucleotides that code for lymphotoxin polypeptide receptors, used for screening antagonists and/or agonists to the receptors; genetic engineering |
| 08/22/2006 | US7094559 Assay to identify estrogen receptor dependent ligands that regulate the hepatic lipase promoter |
| 08/22/2006 | US7094556 Diagnosis and treatment of malignant neoplasms |
| 08/22/2006 | US7094554 Cry proteins; for crop growth and development; pesticides |
| 08/22/2006 | US7094553 Can be used in an assay to determine if a sample is infected with infectious prions, i.e. PrPSc |
| 08/22/2006 | US7094548 Polypeptide for use in purifying and separation of target peptides |
| 08/22/2006 | US7094547 Sperm specific proteins |
| 08/22/2006 | US7094546 screening gene expression inhibition via incubating mrna, determining expression in presence of test compound, then comparing levels; gene knockout |
| 08/22/2006 | US7094544 Genetic test for the identification of carriers of complex vertebral malformations in cattle |
| 08/22/2006 | US7094541 Oligonucleotide probes; viricides; gene therapy |
| 08/22/2006 | US7094539 Bacillus stearothermophilus reverse transcription compositions and kits |
| 08/22/2006 | US7094538 Diagnostic assay for cancer susceptibility |
| 08/22/2006 | US7094537 Micro arrays with structured and unstructured probes |
| 08/22/2006 | US7094536 Generating copies of preferential nucleotide sequences; obtain nucleotide sequences, incubate with primers, extend chain, split bound nucleotides, denature nucleotide sequences, incubate with primer, amplify, recover nucleotide sequences |
| 08/22/2006 | US7094532 Use of polynucleotides and peptides in analysis of human norepinephrine (NE) transporter variants; diagnostic and therapeutic applications; human NE transporter polymorphism |
| 08/22/2006 | US7094531 hybridizing single-stranded DNA containing primer with array probes attached to known sequence, cleaving ligated probes to release label, recording label quantity, then activating double-stranded DNA sequence |
| 08/22/2006 | US7094530 α-1,3-fucosyltransferase |
| 08/22/2006 | US7094424 Cationic lipid compositions targeting angiogenic endothelial cells |
| 08/22/2006 | US7094411 Avirulent, immunogenic flavivirus chimeras |
| 08/22/2006 | US7094410 DNA vaccine against proliferating endothelial cells and methods of use thereof |
| 08/22/2006 | US7094409 Antigen arrays for treatment of allergic eosinophilic diseases |
| 08/22/2006 | US7094408 Immunogenicity using a combination of DNA and vaccinia virus vector vaccines |
| 08/22/2006 | US7094403 Mycobacterium tuberculosis superoxide dismutase |
| 08/22/2006 | US7094400 Transkaryotic implantation |
| 08/22/2006 | US7094399 Use of spliceosome mediated RNA trans-splicing to confer cell selective replication to adenoviruses |
| 08/22/2006 | US7094398 double-stranded vector carries transgenes for stable and efficient gene transfer into diverse cell types or tissues in a CAR- and/or alpha upsilon beta 3/5-independent manner; gene therapy; tissue-targeted therapy |
| 08/22/2006 | US7094391 oral Lime disease vaccination using pure Outer surface protein A specific serum Immunoglobulin A antibodies; immunotherapy |
| 08/22/2006 | US7094201 System and method for genetically treating cardiac conduction disturbances |
| 08/22/2006 | CA2535696A1 Regulation of gene expression using chromatin remodelling factors |
| 08/22/2006 | CA2158960C Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter |
| 08/22/2006 | CA2075052C Hla dqbeta dna typing |
| 08/22/2006 | CA2044468C Canine granulocyte macrophage colony stimulating factor |
| 08/17/2006 | WO2006086730A2 Inhibiting her2 shedding with matrix metalloprotease antagonists |
| 08/17/2006 | WO2006086681A2 Methods of inhibiting smooth muscle cell migration and proliferation |
| 08/17/2006 | WO2006086669A2 Aptamer regulated nucleic acids and uses thereof |
| 08/17/2006 | WO2006086638A2 Targeting lipocalin-2 for cancer therapeutics |
| 08/17/2006 | WO2006086559A1 Self-cure activator |
| 08/17/2006 | WO2006086545A2 Method to identify novel therapeutics |
| 08/17/2006 | WO2006086454A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 08/17/2006 | WO2006086357A2 Adenovirus serotype 36 vectors, nucleic acid and viruses produced thereby |
| 08/17/2006 | WO2006086326A2 Biological production of clavulanic acid and related compounds |
| 08/17/2006 | WO2006085987A2 Rna interference in respiratory epitheial cells |
| 08/17/2006 | WO2006085973A2 Antisense antibacterial method and compound |
| 08/17/2006 | WO2006085913A2 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 08/17/2006 | WO2006085910A2 Endotoxin-free moraxella catarrhalis |
| 08/17/2006 | WO2006085749A1 Plant virus designated tomato torrado virus |
| 08/17/2006 | WO2006085699A1 Transgenic plant capable of detecting environmental burden chemical |
| 08/17/2006 | WO2006085673A1 Hairless transgenic animal |
| 08/17/2006 | WO2006085668A1 Magnetic composite body, production method thereof, method for removing substance with mannose on its surface, and method for concentrating substance with mannose on its surface |
| 08/17/2006 | WO2006085648A1 Novel narcolepsy-related gene |
| 08/17/2006 | WO2006085616A1 Method for amplification of nucleotide sequence |
| 08/17/2006 | WO2006085590A1 TetR EXPRESSING NON-HUMAN TRANSGENIC ANIMAL AND METHOD FOR PRODUCING THE SAME |
| 08/17/2006 | WO2006085589A1 Method of improving sugar metabolism in microorganism |
| 08/17/2006 | WO2006085587A1 Neurosphere-forming agent |
| 08/17/2006 | WO2006085583A1 Cell permeable peptide |
| 08/17/2006 | WO2006085553A1 Anti-tlr6 antibody and utilization of the same |
| 08/17/2006 | WO2006085535A1 Method for producing biopterin using tetrahydrobiopterin biosynthesis enzyme |
| 08/17/2006 | WO2006085518A1 Method for improving antibody |
| 08/17/2006 | WO2006085509A1 Modified pyrroloquinolinequinone-dependent glucose dehydrogenase having excellent substrate-specificity |
| 08/17/2006 | WO2006085482A1 Self-replication factor and amplification method of hematopoietic stem cell |
| 08/17/2006 | WO2006085476A1 Method of preparing probe dna for nucleic acid coding for membrane protein, method of detecting expression of gene coding for membrane protein, and carrier for probe dna immobilization |
| 08/17/2006 | WO2006085451A1 Method for reconstruction of blood cell from gene-transferred hematopoietic cell |
| 08/17/2006 | WO2006085441A1 Antibody for assay of adamts13 activity and method of activity assay |
| 08/17/2006 | WO2006085411A1 Novel adjuvant for evoking immune responce and utilization of the same |
| 08/17/2006 | WO2006085407A1 Method for screening gene associated with hcv level |
| 08/17/2006 | WO2006085402A1 Method of determining resistance to development of bovine leukemia |
| 08/17/2006 | WO2006085104A1 Method for isolating nucleic acids comprising the use of ethylene glycol multimers |
| 08/17/2006 | WO2006085016A1 Stable and long-lasting sirna expression vectors and the applications thereof |
| 08/17/2006 | WO2006085011A1 Means for obtaining avirulent leishmania promastigotes, promastigotes obtained, and the applications thereof |
| 08/17/2006 | WO2006084953A1 Novel microbial enzymes and their use |
| 08/17/2006 | WO2006084868A2 Expression cassettes for regulation of expression in monocotyledonous plants |
| 08/17/2006 | WO2006084758A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype |
| 08/17/2006 | WO2006084754A1 Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products |
| 08/17/2006 | WO2006084753A1 Method for isolating nucleic acids, the nucleic acids being immobilised on a matrix at an increased temperature |
| 08/17/2006 | WO2006084749A2 Rcs 02, a novel gene involved in the biosynthesis of vitamin c |